The Connect Current cover art

The Connect Current

The Connect Current

By: Connect
Listen for free

LIMITED TIME OFFER

£0.99/mo for 3 months - terms apply. Offer ends 24 August 2026.
The Connect Current is your inside look at the people and ideas shaping San Diego’s innovation ecosystem. Produced by Connect, a nonprofit supporting founders and investors for over 40 years, the podcast builds on a legacy of helping high growth companies, including alumni like Cloudbeds, ClickUp, Inhibrx, and NanoCellect Biomedical, grow and scale from San Diego to the global stage. Each episode features relaxed, thoughtful conversations with founders, investors, and community leaders across life science, tech, climate, defense, AI, and more, sharing the stories shaping San Diego innovation. If you’re building, investing, learning, or simply curious about the future of San Diego’s innovation economy, this is your place to stay connected to what’s happening now and what’s next. Science
Episodes
  • Targeted Cancer Therapies and the Fight to Make Treatment Less Fearful featuring Stanley Lewis
    Jul 28 2026

    In this episode of The Connect Current, we sit down with Stanley Lewis, MD, MPH, Founder and CEO of A28 Therapeutics, to explore how targeted cancer therapies can create better options for patients facing difficult diseases. Stanley shares the story behind A28’s targeted oncolytic peptide platform, the company’s lead candidate AT-101, and what it takes to move a clinical-stage biopharmaceutical company from scientific promise toward real-world impact. The conversation dives into patient need, treatment burden, clinical development, capital, partnerships, and why A28’s next chapter as one of Connect’s 2026 Cool Companies reflects the strength of San Diego’s growing life sciences ecosystem.

    Recorded at UC San Diego Park & Market:
    https://parkandmarket.ucsd.edu/

    Learn more about A28 Therapeutics:
    https://www.a28tx.com/

    Show More Show Less
    22 mins
  • Connecting National Security, Startups, and San Diego’s Innovation featuring Scott Tait
    Jul 21 2026

    In this episode of The Connect Current, we sit down with Scott Tait to explore how San Diego can better connect national security needs, university research, dual-use startups, capital, and policy into a stronger innovation system. Drawing on his 27-year Navy career and his work across Lumetec, Startup Science, and the National Security Innovation Catalyst at UC San Diego, Scott shares what it takes to move promising technology from concept to real-world mission impact. The conversation dives into San Diego’s unique national security advantage, where founders and researchers often get stuck, and how stronger pathways between government, academia, startups, industry, and investors can help accelerate innovation that matters.

    Recorded at UC San Diego Park & Market:
    https://parkandmarket.ucsd.edu/

    Learn more about Lumetec:
    https://www.lumetec.com/

    Learn more about the National Security Innovation Catalyst at UC San Diego:
    https://nsic.ucsd.edu/

    Show More Show Less
    20 mins
  • How TL Foundation Turns Community Capital Into San Diego’s Innovation Future featuring Kris Lichter
    Jul 14 2026

    In this episode of The Connect Current, we sit down with Kris Lichter, CEO of TL Foundation, to explore a different approach to investing in innovation. The conversation dives into how TL Foundation is transforming philanthropic capital into long-term investment in San Diego startups, creating an evergreen model that reinvests success back into the region. Kris shares what makes a company a strong fit for the fund, what founders should know before seeking investment, and why building a stronger innovation economy takes founders, investors, donors, and community leaders working together toward long-term impact.

    Recorded at UC San Diego Park & Market:
    https://parkandmarket.ucsd.edu/

    Learn more about TL Foundation:
    http://sandiegotlf.org

    Show More Show Less
    20 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet